Gender Matters in Limb Salvage: What the BEST-CLI Trial Teaches Us About Female Patients and Vascular Surgery

22. July 2025

ALPS RESEARCH HIGHLIGHT INTERVIEW – In the groundbreaking BEST-CLI (Best Endovascular vs. Best Surgical Therapy in Patients with Critical Limb Ischemia) trial, a surprising and important observation emerged: female patients had fewer limb amputations than their male counterparts.

Dr. Katharine McGinigle, vascular surgeon-scientist and a board member of the American Limb Preservation Society (ALPS), led the gender-based secondary analysis of the trial.

Reflecting on the work, she shared:

“After the initial trial was published, many of the investigators formed working groups to analyze specific subgroups. I was fortunate to lead the gender-based research group. We wanted to deeply understand what was happening with the female participants — something all too often overlooked in large trials.”

Historical underrepresentation of women

Historically, women have been underrepresented in cardiovascular and vascular research, and many studies fail to report gender-stratified outcomes.

Yet gender can profoundly influence both disease progression and surgical outcomes.

American Limb Preservation Society Expands Leadership Team with Appointment of Two Esteemed Board Members to Drive Innovation in Limb Preservation

 

“There are very few female-specific studies,” McGinigle noted. “We know that atherosclerosis risk changes dramatically pre- and post-menopause, and that women and men face different risks and technical challenges during vascular surgery.”

In their analysis, the team found that women with chronic limb-threatening ischemia (CLTI) who had autologous saphenous vein available for bypass surgery fared significantly better with open surgery than with endovascular treatment — mirroring the overall trial findings.

But more intriguingly, when compared with male patients, women had lower amputation rates, even though their comorbidity profiles and reintervention rates were similar.

“That was a really interesting and encouraging finding,” McGinigle explained. “It suggests that, within a high-quality care framework like BEST-CLI, we might be mitigating some of the disparities in outcomes that have been seen in prior retrospective studies.”

This finding could reflect the benefits of participating in a structured, protocol-driven care model and being treated at experienced, multidisciplinary centers.

“If females are plugged into a good healthcare regimen — like those at BEST-CLI centers — we may be able to reduce some of the gender disparities that exist in vascular outcomes. That’s our hypothesis,” said McGinigle.

Why It Matters

This work reinforces the importance of inclusive research and gender-stratified reporting in vascular surgery. It also highlights the need for patient-centered decision-making, ensuring that women are not overlooked when evaluating treatment strategies for limb-threatening ischemia.

“Our study isn’t definitive — it wasn’t powered for these subgroup analyses — but it’s a powerful signal. It shows us the direction we need to go,” McGinigle said.

Full author group: Katharine L McGinigle, Gheorghe Doros, Olamide Alabi, Benjamin S Brooke, Ageliki Vouyouka, Jade Hiramoto, Kristofer Charlton-Ouw, Michael B Strong, Kenneth Rosenfield, Matthew T Menard, Alik Farber, Kristina A Giles.

Read the full study here: https://pubmed.ncbi.nlm.nih.gov/39368637/ 

 


Become a Member & Join us for DFCon

The American Limb Preservation Society continues to support and amplify research like this through its educational initiatives and collaborations. Join us at DFCon, the Diabetic Foot Conference, October 23–25, 2025, where leaders in limb preservation will share the latest in science, strategy, and clinical care. Dive deeper into multidisciplinary care models like the “Toe and Flow” approach, pioneered by ALPS leadership, and explore innovations that are reducing amputation rates and transforming diabetic foot care.

Join a dynamic and growing global network of healthcare professionals committed to interdisciplinary collaboration.

ALPS members gain access to a professional networking platform, exclusive educational content, clinical resources, and leadership opportunities. Members get a 10% discount on their DFCon registration fee.

🔗 Become a Member Today: https://alps.styleinc.eu/become-a-member/


Partner with Us

Strategic partnerships are at the heart of ALPS’s work. If your organization is focused on healthcare innovation, diabetes care, wound healing, or public health, we invite you to collaborate on educational programs, advocacy initiatives, or research projects. Let’s create impact together.

🔗 Learn About Strategic Partnerships: https://alps.styleinc.eu/alps-strategic-partners/


Related Articles

Dr. David G. Armstrong Named 2025 Global PAD Patient Champion

The American Limb Preservation Society (ALPS) proudly announces that Dr. David G. Armstrong has been named the 2025 Global Peripheral Artery Disease (PAD) Patient Champion — a unique honor nominated by patients. As Founding President of ALPS and Distinguished Professor of Surgery at USC, Dr. Armstrong’s decades of work have bridged clinical innovation with compassionate advocacy, empowering underserved populations and driving global collaborations in limb preservation.

read more